Tags

Type your tag names separated by a space and hit enter

From SARS to COVID-19: What lessons have we learned?
J Infect Public Health. 2020 Nov; 13(11):1611-1618.JI

Abstract

After the outbreak of severe acute respiratory syndrome (SARS) in November 2002, coronaviruses (CoVs) received worldwide attention. On December 1, 2019, the first case of coronavirus disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), was reported in Wuhan, China, and CoVs returned to public view. On January 30, 2020, the World Health Organization (WHO) declared that the COVID-19 epidemic is a public health emergency of international concern (PHEIC), and on March 11, 2020, the WHO classified COVID-19 as a pandemic disease. As of July 31, 2020, COVID-19 has affected 216 countries and regions, with 17,064,064 confirmed cases and 668,073 deaths, and the number of new cases has been increasing daily. Additionally, on March 19, 2020, there were no new confirmed cases in China, providing hope and valuable experience for the international community. In this review, we systematically compare COVID-19 and SARS in terms of epidemiology, pathogenesis and clinical characteristics and discuss the current treatment approaches, scientific advancements and Chinese experience in fighting the epidemic to combat the novel coronavirus pandemic. We also discuss the lessons that we have learned from COVID-19 and SARS.

Authors+Show Affiliations

Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China. Electronic address: yuwx999@sina.com.Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China. Electronic address: wenmei-wang@hotmail.com.

Pub Type(s)

Comparative Study
Journal Article
Review

Language

eng

PubMed ID

32888871

Citation

Liu, Qin, et al. "From SARS to COVID-19: what Lessons Have We Learned?" Journal of Infection and Public Health, vol. 13, no. 11, 2020, pp. 1611-1618.
Liu Q, Xu K, Wang X, et al. From SARS to COVID-19: What lessons have we learned? J Infect Public Health. 2020;13(11):1611-1618.
Liu, Q., Xu, K., Wang, X., & Wang, W. (2020). From SARS to COVID-19: What lessons have we learned? Journal of Infection and Public Health, 13(11), 1611-1618. https://doi.org/10.1016/j.jiph.2020.08.001
Liu Q, et al. From SARS to COVID-19: what Lessons Have We Learned. J Infect Public Health. 2020;13(11):1611-1618. PubMed PMID: 32888871.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - From SARS to COVID-19: What lessons have we learned? AU - Liu,Qin, AU - Xu,Kaiyuan, AU - Wang,Xiang, AU - Wang,Wenmei, Y1 - 2020/08/21/ PY - 2020/04/21/received PY - 2020/08/03/revised PY - 2020/08/08/accepted PY - 2020/9/6/pubmed PY - 2020/11/18/medline PY - 2020/9/5/entrez KW - Chinese experience KW - Coronavirus disease 2019 (COVID-19) KW - Pandemic KW - SARS KW - SARS-CoV-2 SP - 1611 EP - 1618 JF - Journal of infection and public health JO - J Infect Public Health VL - 13 IS - 11 N2 - After the outbreak of severe acute respiratory syndrome (SARS) in November 2002, coronaviruses (CoVs) received worldwide attention. On December 1, 2019, the first case of coronavirus disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), was reported in Wuhan, China, and CoVs returned to public view. On January 30, 2020, the World Health Organization (WHO) declared that the COVID-19 epidemic is a public health emergency of international concern (PHEIC), and on March 11, 2020, the WHO classified COVID-19 as a pandemic disease. As of July 31, 2020, COVID-19 has affected 216 countries and regions, with 17,064,064 confirmed cases and 668,073 deaths, and the number of new cases has been increasing daily. Additionally, on March 19, 2020, there were no new confirmed cases in China, providing hope and valuable experience for the international community. In this review, we systematically compare COVID-19 and SARS in terms of epidemiology, pathogenesis and clinical characteristics and discuss the current treatment approaches, scientific advancements and Chinese experience in fighting the epidemic to combat the novel coronavirus pandemic. We also discuss the lessons that we have learned from COVID-19 and SARS. SN - 1876-035X UR - https://www.unboundmedicine.com/medline/citation/32888871/From_SARS_to_COVID_19:_What_lessons_have_we_learned L2 - https://linkinghub.elsevier.com/retrieve/pii/S1876-0341(20)30600-6 DB - PRIME DP - Unbound Medicine ER -